ALEC · Alector, Inc.

$1.52 +0.00 (+0.00%) At close · Jul 29

Market Cap

$168.76M

111.03M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Arnon Rosenthal	CEO	$678,100	—	$422,876	$558,216	$325,488	$10,338	$1,995,018
Dr. Sara Kenkare-Mitra	President and Head of Research and Development	$614,301	—	$77,710	$17,810	$314,200	$551,129	$1,575,150
Neil Berkley	CFO	$455,000	$91,000	$128,135	$219,202	$152,880	$6,242	$1,052,459

Fiscal 2024

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Arnon Rosenthal	CEO	$674,808	—	$2,777,775	—	$203,430	$10,328	$3,666,341
Dr. Sara Kenkare-Mitra	President and Head of Research and Development	$624,367	—	$1,365,000	—	$552,992	$7,322	$2,549,681
Neil Berkley	CFO	$350,000	—	$1,816,657	—	$117,214	$5,955	$2,289,826
Marc Grasso	CFO	$514,777	—	$984,620	—	$182,230	$6,242	$1,687,869
Gary Romano	CMO	$528,963	—	$838,929	—	$187,686	$8,564	$1,564,142

Fiscal 2023

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Arnon Rosenthal	CEO	$653,625	—	$2,576,448	$614,323	$400,000	$10,611	$4,255,007
Dr. Sara Kenkare-Mitra	President and Head of Research and Development	$598,500	—	$1,060,128	$252,684	$687,580	$7,322	$2,606,214
Marc Grasso	CFO	$496,800	—	$797,040	$190,092	$225,672	$6,242	$1,715,846
Gary Romano	CMO	$502,312	—	$699,840	$166,910	$241,295	$8,564	$1,618,921

Fiscal 2022

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Dr. Sara Kenkare-Mitra	President and Head of Research and Development	$570,000	—	$3,018,736	$4,662,171	$612,180	$7,322	$8,870,409
Marc Grasso	CFO	$432,923	$103,000	$337,741	$4,935,992	$200,448	$1,676	$6,011,780
Gary Romano	CMO	$289,872	—	$1,038,345	$2,451,835	$118,682	$7,165	$3,905,899
Arnon Rosenthal	CEO	$621,413	—	$1,694,939	$800,515	$389,340	$9,191	$3,515,398
Robert King	Former Chief Development Officer	$385,273	—	$204,109	$96,400	—	$6,935	$692,718
Linda Rubinstein	Former Interim Chief Financial Officer	$116,400	—	—	—	—	—	$116,400

Fiscal 2021

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Arnon Rosenthal	CEO	$575,400	—	$1,801,875	$6,837,954	$388,160	$9,191	$9,612,580
Shehnaaz Suliman	COO	$500,000	—	$1,201,250	$816,282	—	$773,225	$3,290,757
Robert King	Former Chief Development Officer	$437,500	—	$681,317	$584,043	$214,016	$7,322	$1,924,198
Calvin Yu	Vice President, Finance	$308,333	$90,000	$470,722	$385,238	$114,576	$6,784	$1,375,653
Robert Paul	Former Chief Medical Officer	$366,699	—	$720,750	—	—	$38,866	$1,126,315
Dr. Sara Kenkare-Mitra	President and Head of Research and Development	$25,942	$500,000	—	—	$26,813	$28	$526,841
Linda Rubinstein	Former Interim Chief Financial Officer	$306,150	—	—	—	—	—	$306,150

Fiscal 2020

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Shehnaaz Suliman	COO	$471,667	—	—	$7,667,378	$200,250	$5,841	$8,345,136
Arnon Rosenthal	CEO	$554,167	—	—	$3,096,204	—	$11,858	$3,662,229
Robert King	Former Chief Development Officer	$414,583	—	—	$835,973	$134,300	$7,322	$1,392,178
Robert Paul	Former Chief Medical Officer	$432,017	—	—	$743,088	$130,240	$6,242	$1,311,587
Former ChiefMedicalOfficer	—	$432,017	—	—	$743,088	$130,240	$6,242	$1,311,587
Calvin Yu	Vice President, Finance	$295,000	—	—	$457,455	$71,100	$4,771	$828,326

Fiscal 2019

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Arnon Rosenthal	CEO	$525,000	—	—	$5,984,524	$341,250	$3,564	$6,854,338
Robert Paul	Former Chief Medical Officer	$392,100	—	—	$1,726,305	$188,208	$1,242	$2,307,855
Former ChiefMedicalOfficer	—	$392,100	—	—	$1,726,305	$188,208	$1,242	$2,307,855
Robert King	Former Chief Development Officer	$362,500	—	—	$1,726,305	$166,750	$2,322	$2,257,877

Fiscal 2018

Executive	Role	Salary	Bonus	Stock Awards	Option Awards	Incentive	Other	Total
Arnon Rosenthal	CEO	$396,764	—	—	$4,816,115	$237,540	$3,564	$5,453,983
Robert Paul	Former Chief Medical Officer	$326,367	$43,750	—	$2,707,815	$136,920	$1,243	$3,216,095
Robert King	Former Chief Development Officer	$352,297	—	—	$1,570,355	$147,800	$2,323	$2,072,775

Executive changes

Person	Role	Change	Effective	Filed
Neil Berkley	Chief Financial Officer	Appointed	2025-12-10	2025-12-12

Key facts CIK 1653087 CUSIP 014442107 13F (30d) 20 filings 20 filers Visit website Investor relations